Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments
Lorenzo Belluzzi,1,2,* Giulio Martinelli,1,2,* Bianca Medici,1,2 Alessandro Farina,1 Enrica Martinelli,1 Fabio Canino,1,2 Federica Caggia,2,3 Alessia Molinaro,1 Monica Barbolini,2,4 Fabio Tamburrano,1 Luca Moscetti,2,4 Federico Piacentini,1,2 Massimo Dominici,1 Claudia Omarini2,4 1De...
Saved in:
Main Authors: | Belluzzi L, Martinelli G, Medici B, Farina A, Martinelli E, Canino F, Caggia F, Molinaro A, Barbolini M, Tamburrano F, Moscetti L, Piacentini F, Dominici M, Omarini C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-01-01
|
Series: | Breast Cancer: Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/update-on-pulmonary-toxicity-induced-by-new-breast-cancer-treatments-peer-reviewed-fulltext-article-BCTT |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating risk factors for Trastuzumab-Deruxtecan Pneumonitis in patients with metastatic breast cancer
by: Jonathan Henricks, et al.
Published: (2025-02-01) -
“Etiology and CT pattern in patients with interstial lung disease”: shift in the trends?
by: Abhishek Samdesi, et al.
Published: (2023-12-01) -
The Real-World Clinical Outcomes of Heavily Pretreated HER2+ and HER2-Low Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan at a Single Centre
by: Anna-Maria Lazaratos, et al.
Published: (2024-12-01) -
Clinical characteristics and prognosis of amyopathic dermatomyositis patients with interstitial lung disease: insights from a retrospective cohort
by: Yanan Ying, et al.
Published: (2025-02-01) -
Connective tissue disease-associated interstitial lung disease – A multicenter observational study from India
by: Sham Santhanam, et al.
Published: (2021-01-01)